Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients

• Main Authors: Sherri Borman (Author), Jeff Wilkinson (Author), Lauren Meldi-Sholl (Author), Clare Johnson (Author), Kelsey Carter (Author), Kyle R. Covington (Author), Alison L. Fitzgerald (Author), Sarah J. Kurley (Author), Aaron S. Farberg (Author), Matthew S. Goldberg (Author), Federico A. Monzon (Author), Kristen Oelschlager (Author), Robert W. Cook (Author)
• Format: Book
• Published: BMC, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background To improve identification of patients with cutaneous squamous cell carcinoma (SCC) at high risk for metastatic disease, the DecisionDx-SCC assay, a prognostic 40-gene expression profile (40-GEP) test, was developed and validated. The 40-GEP assay utilizes RT-PCR gene expression a...